Personal information

Websites & social links

ResearchGate

Other IDs

Researcher Name Resolver ID: 1000000732405
Scopus Author ID: 55826922800
Loop profile: 907065

Keywords

Cancer stem cell, EpCAM, Autophagy, Drug re-positioning, CD44, Heterogeneity, Melanoma, hepatic tumor, glioblastoma, cancer-associated fibroblasts

Countries

Japan

Activities

Collapse all

Employment (4)

Juntendo University School of Medicine : Tokyo, JP

2018-12-01 to present | Assistant Professor (Department of Pathology and Oncology)
Employment
Source: Self-asserted source
Go Yoshida

Japan Society for the Promotion of Science: Tokyo, JP

2015-04-01 to 2018-03-31 (Pathological Cell Department, Medical Research Institute, Tokyo Medical and Dental University)
Employment
Source: Self-asserted source
Go Yoshida

Tokyo Medical and Dental University: Tokyo, JP

2014-04-01 to 2015-03-31 (Department of Stem Cell Biology, Medical Research Institute)
Employment
Source: Self-asserted source
Go Yoshida

The University of Tokyo Hospital: Tokyo, JP

2010-04-01 to 2011-03-31
Employment
Source: Self-asserted source
Go Yoshida

Education and qualifications (2)

Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka: Shinjuku-ku, Tokyo, JP

2011-04-01 to 2014-03-20 | M.D.,Ph.D. (Gene Regulation Department)
Education
Source: Self-asserted source
Go Yoshida

Keio University School of Medicine: Tokyo, JP

2004-04-01 to 2010-03-31 | M.D, Ph.D.
Education
Source: Self-asserted source
Go Yoshida

Funding (5)

Elucidation of the mechanism of metabolic reprogramming regulated by EpCAM

2020-04 to 2023-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER:

20K16340
Source: Self-asserted source
Go Yoshida

Functional analysis of FOXQ1 in the development of metaplastic breast carcinoma

2019-09 to 2021-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 19K23898
Source: Self-asserted source
Go Yoshida

Pathophysiological role of autophagy in epithelial-mesenchymal transition

2016-04 to 2019-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 16K19103
Source: Self-asserted source
Go Yoshida

Identification of melanocytic stem cells and machinery underlying the development of acral melanoma

2015-04 to 2018-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 923595
Source: Self-asserted source
Go Yoshida

Identification of melanocytic stem cells and machinery underlying the development of acral melanoma

2014-04 to 2015-03 | Grant
Japan Society for the Promotion of Science (Tokyo, Experimental Pathology, JP)
GRANT_NUMBER: 26893062
Source: Self-asserted source
Go Yoshida

Works (38)

The Hallmarks of Ovarian Cancer Stem Cells and Niches: Exploring Their Harmonious Interplay in Therapy Resistance.

Seminars in cancer biology
2021-04-01 | Journal article
DOI: 10.1016/j.semcancer.2021.03.038
PMID: 33812986
Source: Self-asserted source
Go Yoshida

Molecular pathology underlying the robustness of cancer stem cells.

Regenerative therapy
2021-03-25 | Journal article
DOI: 10.1016/j.reth.2021.02.002
PMID: 33869685
Source: Self-asserted source
Go Yoshida

The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells

Metabolites
2021-01 | Journal article | Author
DOI: 10.3390/metabo11010027
Contributors: Go Yoshida
Source: check_circle
Multidisciplinary Digital Publishing Institute

The interplay between apoptosis and ferroptosis mediated by ER stress

Apoptosis
2020-11-07 | Journal article
DOI: 10.1007/s10495-020-01641-1
Part of ISSN: 1360-8185
Part of ISSN: 1573-675X
Source: Self-asserted source
Go Yoshida

Sebaceous gland: Milestones of 30 years modeling research dedicated to the “brain of the skin”

Experimental Dermatology
2020-09-02 | Journal article
DOI: 10.1111/exd.14184
Part of ISSN: 0906-6705
Part of ISSN: 1600-0625
Source: Self-asserted source
Go Yoshida

Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways

Journal of Experimental & Clinical Cancer Research
2020-06 | Journal article
DOI: 10.1186/s13046-020-01611-0
Part of ISSN: 1756-9966
Source: Self-asserted source
Go Yoshida

The therapeutic strategy of drug re-positioning to induce autophagic cell death in brain malignancy.

Apoptosis : an international journal on programmed cell death
2020-06-24 | Journal article
DOI: 10.1007/s10495-020-01617-1
PMID: 32583319
Source: Self-asserted source
Go Yoshida
grade
Preferred source (of 2)‎

Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells

Frontiers in Oncology
2020-05-27 | Journal article
DOI: 10.3389/fonc.2020.00791
Part of ISSN: 2234-943X
Source: Self-asserted source
Go Yoshida

[Ⅰ. Molecular Mechanisms Underlying the Development and Progression of Malignant Melanoma].

Gan to kagaku ryoho. Cancer & chemotherapy
2020-04-01 | Journal article
PMID: 32389958
Source: Self-asserted source
Go Yoshida

Comment on “GRP94 promotes brain metastasis by engaging pro-survival autophagy”

Neuro-Oncology
2020-03-27 | Journal article
DOI: 10.1093/neuonc/noaa017
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Source: Self-asserted source
Go Yoshida

Applications of patient-derived tumor xenograft models and tumor organoids.

Journal of hematology & oncology
2020-01 | Journal article
DOI: 10.1186/s13045-019-0829-z
PMID: 31910904
PMC: PMC6947974
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study.

Cancers
2019-07-15 | Journal article
DOI: 10.3390/cancers11070985
PMID: 31311148
Source: Self-asserted source
Go Yoshida

Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies.

International journal of molecular sciences
2019-05-07 | Journal article
DOI: 10.3390/ijms20092256
PMID: 31067787
Source: Self-asserted source
Go Yoshida

Beyond Stanton and Pott hypothesis; carbon nanotubes-induced malignant mesothelioma as a disease of gene loss.

Journal of occupational health
2019-02 | Journal article
DOI: 10.1002/1348-9585.12019
PMID: 30773744
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise.

Journal of occupational health
2019-02 | Journal article
DOI: 10.1002/1348-9585.12015
PMID: 30767335
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms.

The oncologist
2018-09 | Journal article
DOI: 10.1634/theoncologist.2018-0148
PMID: 30181312
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Legionnaires' disease as an occupational risk related to decontamination work after the Fukushima nuclear disaster: A case report.

Journal of occupational health
2018-08 | Journal article
DOI: 10.1539/joh.2018-0138-lte
PMID: 30122733
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Molecular machinery underlying the autophagic regulation by MDA-9/Syntenin leading to anoikis resistance of tumor cells.

Proceedings of the National Academy of Sciences of the United States of America
2018-08 | Journal article
DOI: 10.1073/pnas.1810152115
PMID: 30087191
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

[The emerging role of artificial intelligence in clinical and basic medicine].

Sangyo eiseigaku zasshi = Journal of occupational health
2018-07 | Journal article
DOI: 10.1539/sangyoeisei.2018-009-w
PMID: 30058601
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Emerging roles of Myc in stem cell biology and novel tumor therapies.

Journal of experimental & clinical cancer research : CR
2018-07 | Journal article
DOI: 10.1186/s13046-018-0835-y
PMID: 30053872
PMC: PMC6062976
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Comment on "Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients".

Molecular diagnosis & therapy
2018-06 | Journal article
DOI: 10.1007/s40291-018-0342-z
PMID: 29922884
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?

Proceedings of the National Academy of Sciences of the United States of America
2018-06 | Journal article
DOI: 10.1073/pnas.1808092115
PMID: 29941608
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

The heterogeneity of cancer stem-like cells at the invasive front.

Cancer cell international
2017 | Journal article
DOI: 10.1186/s12935-017-0393-y
PMID: 28289330
PMC: PMC5307924
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.

Journal of hematology & oncology
2017-03 | Journal article
DOI: 10.1186/s13045-017-0436-9
PMID: 28279189
PMC: PMC5345270
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

In Situ Characterization of Bak Clusters Responsible for Cell Death Using Single Molecule Localization Microscopy.

Scientific reports
2016 | Journal article
DOI: 10.1038/srep27505
PMID: 27293178
PMC: PMC4904369
Contributors: Nasu Y; Benke A; Arakawa S; Yoshida GJ; Kawamura G; Manley S; Shimizu S; Ozawa T
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Emerging role of epithelial-mesenchymal transition in hepatic cancer.

Journal of experimental & clinical cancer research : CR
2016-09 | Journal article
DOI: 10.1186/s13046-016-0419-7
PMID: 27619936
PMC: PMC5020508
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Therapeutic strategies targeting cancer stem cells.

Cancer science
2016-01 | Journal article
DOI: 10.1111/cas.12817
PMID: 26362755
PMC: PMC4724810
Contributors: Yoshida GJ; Saya H
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Metabolic reprogramming: the emerging concept and associated therapeutic strategies.

Journal of experimental & clinical cancer research : CR
2015 | Journal article
DOI: 10.1186/s13046-015-0221-y
PMID: 26445347
PMC: PMC4595070
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Mast Cells, Mastocytosis, and Related Disorders.

The New England journal of medicine
2015-11 | Journal article
DOI: 10.1056/nejmc1510021#sa2
PMID: 26535530
Contributors: Yoshida GJ
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Dynamic subcellular localization of aquaporin-7 in white adipocytes.

FEBS letters
2015-02 | Journal article
DOI: 10.1016/j.febslet.2015.01.025
PMID: 25643985
Contributors: Miyauchi T; Yamamoto H; Abe Y; Yoshida GJ; Rojek A; Sohara E; Uchida S; Nielsen S; Yasui M
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells.

Oncogene
2014-07 | Journal article
DOI: 10.1038/onc.2013.356
PMID: 23975421
Contributors: Oshima H; Ishikawa T; Yoshida GJ; Naoi K; Maeda Y; Naka K; Ju X; Yamada Y; Minamoto T; Mukaida N et al.
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

EpCAM expression in the prostate cancer makes the difference in the response to growth factors.

Biochemical and biophysical research communications
2014-01 | Journal article
DOI: 10.1016/j.bbrc.2013.11.093
PMID: 24309103
Contributors: Yoshida GJ; Saya H
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation.

Biochemical and biophysical research communications
2014-01 | Journal article
DOI: 10.1016/j.bbrc.2013.12.016
PMID: 24333422
Contributors: Yoshida GJ; Saya H
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Three-dimensional culture of sebaceous gland cells revealing the role of prostaglandin E2-induced activation of canonical Wnt signaling.

Biochemical and biophysical research communications
2013-09 | Journal article
DOI: 10.1016/j.bbrc.2013.07.129
PMID: 23948691
Contributors: Yoshida GJ; Saya H; Zouboulis CC
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.

Nature communications
2012 | Journal article
DOI: 10.1038/ncomms1892
PMID: 22673910
Contributors: Yae T; Tsuchihashi K; Ishimoto T; Motohara T; Yoshikawa M; Yoshida GJ; Wada T; Masuko T; Mogushi K; Tanaka H et al.
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy.

BMC cancer
2012 | Journal article
DOI: 10.1186/1471-2407-12-444
PMID: 23031740
PMC: PMC3488581
Contributors: Yoshida GJ; Fuchimoto Y; Osumi T; Shimada H; Hosaka S; Morioka H; Mukai M; Masugi Y; Sakamoto M; Kuroda T
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

[Therapeutic strategy for breast cancer stem cells].

Nihon rinsho. Japanese journal of clinical medicine
2012-09 | Journal article
PMID: 23350400
Contributors: Yoshida GJ; Saya H
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

[Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].

Clinical calcium
2011-03 | Journal article
DOI: clica1103411417
PMID: 21358063
Contributors: Yoshida GJ; Saya H
Source: Self-asserted source
Go Yoshida via Europe PubMed Central

Peer review (65 reviews for 8 publications/grants)

Review activity for Cancer cell international. (34)
Review activity for Cellular & Molecular Biology Letters. (2)
Review activity for Journal of experimental & clinical cancer research. (12)
Review activity for Journal of hematology & oncology. (5)
Review activity for Journal of translational medicine. (1)
Review activity for Laboratory investigation. (1)
Review activity for Metabolomics. (1)
Review activity for Molecular cancer (9)
How many people are using ORCID?